Umstellung von Carbamazepin oder Oxcarbazepin auf Topiramat bei Jugendlichen und Erwachsenen mit Epilepsie

@article{Kowalik2008UmstellungVC,
  title={Umstellung von Carbamazepin oder Oxcarbazepin auf Topiramat bei Jugendlichen und Erwachsenen mit Epilepsie},
  author={Artur Kowalik and Wilhelm Rimpau and Hans Olov Adam and Frank Kuehn and Joop C. van Oene and Andreas Schreiner and Modest Bogdanow and Barbara Schaeuble and f{\"u}r die TOPMAT-EPY-405-Pr{\"u}f{\"a}rzte},
  journal={Zeitschrift f{\"u}r Epileptologie},
  year={2008},
  volume={21},
  pages={69-78}
}
ObjectiveTo explore effectiveness, tolerability and changes in quality of life in patients with epilepsy converting to topiramate (TPM) from carbamazepine (CBZ) or oxcarbazepine (OXC) due to insufficient effectiveness and/or tolerability.MethodsA multicenter, open-label, non-interventional trial was used to examine patients (≥12 years) with epilepsy, changing to TPM monotherapy from baseline mono- or combination therapy with CBZ or OXC. TPM was added to the existing antiepileptic drug (AED… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 47 REFERENCES

Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam

JA Cramer, C Arrigo, HG Van, EB Bromfield
  • Epilepsy Res
  • 2000
VIEW 14 EXCERPTS
HIGHLY INFLUENTIAL

Shorvon SD (2007) Results of treatment changes in patients with apparently drug-resistant chronic epilepsy

AL Luciano
  • Ann Neurol
  • 2007
VIEW 16 EXCERPTS
HIGHLY INFLUENTIAL

Defining intractable epilepsy.

  • Advances in neurology
  • 2006
VIEW 1 EXCERPT